3D printing in health - BioBridge workshop

3D printing in health - BioBridge workshop

Actions and Detail Panel


Date and time


Online event

The latest Trans-Tasman BioBridge workshop

About this event

The applications for 3D printing technology have been growing rapidly in recent years with the technique becoming easier to access and incredible research advances across the globe. Today, this technology is seeing greater use in medical applications and it has emerged as a disruptive technology in orthopaedic and trauma surgery. 3D printing is used to create customised devices, instruments and models of patient anatomy. These are used in surgical planning, teaching and communication, as well as implants. 3D bioprinting is the extension of conventional 3D printing to using cells, growth factors and biomaterials to create biomedical parts that mimic natural tissues, ultimately to use in implants and repairs. Current research in this field is advancing regenerative engineering and pharmaceutical development.

This workshop brings together an expert panel on 3D printing covering the latest research, possible applications and commercialisation of such technologies. Khoon Lim from NZ's University of Otago will start the session with his research into bio-inks and possible clinical applications. He is followed by Aidan O'Mahony from Australian company Inventia Lifesciences who will speak about Ligō: an in-situ bioprinting for treatment of full thickness skin wounds. In this talk, he will discuss Inventia's vision and progress towards translating it's core technology, which currently powers it's flagship product RASTRUM, to the clinic. Inventia's Ligō platform is currently in pre-clinical trials for treatment of full thickness skin wounds with the first-in-human pilot studies planned for late 2023. Lastly, Seamus Tredinnick will discuss the orthopedic applications for 3D printing that are used at OssAbility in Christchurch, NZ.

This BioBridge workshop is being hosted virtually, however we will also have a hub at the Auckland Bioengineering Institute (ABI) to view this in person and connect with others.


Associate Professor Khoon Lim is the Director of the Light Activated Biomaterials research group at the University of Otago Christchurch, New Zealand. He has won >20 competitive national and international awards, including the prestigious Jean Leray Award from the European Society for Biomaterials and Tissue Engineering, and Young Investigator Award from the International Society for Biofrabrications, and his research has led to commercialisation of bioinks licensed to a US-based company.

Dr Aidan O'Mahony is a Founder and Chief Technology Officer at Inventia Lifescience. He led the development of the company’s revolutionary core technology for 3D bio-printing along with its commercialisation in Inventia’s flagship 3D bio-printing platform, RASTRUM. He is now focused on translating this core technology to the clinic to transform human health and improve patient outcomes

Dr Seamus Tredinnick is the founder and CEO of OssAbility. OssAbility develops and produces veterinary orthopaedic implants, surgical guides and decision support. Seamus' background is in mechanical engineering (PhD) and he has extensive experience in the medical device industry and commercial applications of additive manufacturing.

Share with friends